Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 1 day ago • ZTS
Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings
Seeking Alpha • 3 days ago • ZTS
Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript
Benzinga • 3 days ago • ZTS
Zoetis Stock Outlook Clouded By Rising Competitive Pressures
Zacks Investment Research • 3 days ago • ZTS
ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Seeking Alpha • 3 days ago • ZTS
Zoetis: No Longer A Growth Stock
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.